DD266351A5 - Verfahren zur herstellung von (+)-1-isopropylamino-3-[o-(pyrrol-1-yl)-phonoxy]-2-propanol - Google Patents

Verfahren zur herstellung von (+)-1-isopropylamino-3-[o-(pyrrol-1-yl)-phonoxy]-2-propanol Download PDF

Info

Publication number
DD266351A5
DD266351A5 DD87308190A DD30819087A DD266351A5 DD 266351 A5 DD266351 A5 DD 266351A5 DD 87308190 A DD87308190 A DD 87308190A DD 30819087 A DD30819087 A DD 30819087A DD 266351 A5 DD266351 A5 DD 266351A5
Authority
DD
German Democratic Republic
Prior art keywords
pyrrol
propanol
phenoxy
isopropylamino
enantiomer
Prior art date
Application number
DD87308190A
Other languages
German (de)
English (en)
Inventor
Franz Ostermayer
Joachim Jaekel
Nicole Veillon
Original Assignee
Ciba-Geigy Ag,Ch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba-Geigy Ag,Ch filed Critical Ciba-Geigy Ag,Ch
Publication of DD266351A5 publication Critical patent/DD266351A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DD87308190A 1986-10-24 1987-10-22 Verfahren zur herstellung von (+)-1-isopropylamino-3-[o-(pyrrol-1-yl)-phonoxy]-2-propanol DD266351A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4235/86A CH668185A5 (de) 1986-10-24 1986-10-24 Verwendung von 1-isopropylamino-3-(o-(1-pyrrolyl)-phenoxy)-2-propanol zur herstellung von pharmazeutischen praeparaten.

Publications (1)

Publication Number Publication Date
DD266351A5 true DD266351A5 (de) 1989-03-29

Family

ID=4272328

Family Applications (1)

Application Number Title Priority Date Filing Date
DD87308190A DD266351A5 (de) 1986-10-24 1987-10-22 Verfahren zur herstellung von (+)-1-isopropylamino-3-[o-(pyrrol-1-yl)-phonoxy]-2-propanol

Country Status (4)

Country Link
JP (1) JPS63115858A (ja)
CH (1) CH668185A5 (ja)
DD (1) DD266351A5 (ja)
ZA (1) ZA877973B (ja)

Also Published As

Publication number Publication date
ZA877973B (en) 1988-04-25
CH668185A5 (de) 1988-12-15
JPS63115858A (ja) 1988-05-20

Similar Documents

Publication Publication Date Title
EP1202969B1 (de) Biphenylderivate, ihre herstellung und ihre verwendung als mtp-inhibitor
DE3047142C2 (de) Basische 1,7,7-Trimethylbicyclo[2,2,1]heptyläther, Verfahren zur Herstellung derselben und diese enthaltende Arzneimittel
AT394552B (de) Verfahren zur herstellung des neuen n-(2-(4-fluor-phenyl)-1-methyl)-aethyl-n-methyl- propinylamin und isomeren und salzen desselben
DE69611728T2 (de) N-(4-substituerte benzyl)-2-aminolactamderivate
DE69935331T2 (de) Verfahren und verbindungen zur behandlung der depression
EP0726265B1 (de) Antineurodegenerativ wirksame 10-Aminoaliphatyl-dibenz- b,f oxepine
DE69216260T2 (de) Piperidinderivate
FR2533564A1 (fr) Derives de la piperazine presentant une activite anticholinergique et/ou antihistaminique
DE69414264T2 (de) 1-arylcycloalkyl sulfide, sulfoxide und sulfone zur behandlung von depression, angst und morbus parkinson
DE3927049A1 (de) Halogenalkyl-phenyl-ketone und deren hydrate, ihre herstellung und verwendung
EP0065295A1 (de) Substituierte Tryptaminderivate von Thienyloxypropanolaminen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen sowie ihre Verwendung
DE2656088A1 (de) Neues benzylalkoholderivat und verfahren zu seiner herstellung
DD279238A5 (de) Verfahren zur herstellung von benzocycloheptenderivaten
EP0389425B1 (de) Neue Benzothiopyranylamine
DE2507429C2 (de) Aminosäureester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD202144A5 (de) Verfahren zur herstellung substituierter, aliphatischer sekundaeramine
DD266351A5 (de) Verfahren zur herstellung von (+)-1-isopropylamino-3-[o-(pyrrol-1-yl)-phonoxy]-2-propanol
EP0322361A2 (de) Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen
EP0117531B1 (de) N-(3-Trifluormethylphenyl)-N'-propargylpiperazin, seine Herstellung und Verwendung
DE3735641A1 (de) (+)-1-isopropylamino-3-(o-(pyrrol-1-yl) -phenoxy)-propanol, verfahren zu seiner herstellung sowie pharmazeutische praeparate und deren verwendung
DE2619617A1 (de) Amine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel
DD148633A5 (de) Verfahren zur herstellung von hexahydro-1,4-oxazepinen
DE2412388A1 (de) Dibenzothiophenderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
EP0167945B1 (de) Phenylethylaminopropiophenon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0031910B1 (de) Anilinderivate, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung